Claritas Pharmaceuticals, Inc. (CLAZF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 8, 2026
Claritas Pharmaceuticals Market Cap
Claritas Pharmaceuticals has a market cap or net worth of $38 as of October 9, 2026. It is the 53,048th most valuable company in the world and the 9,072nd biggest in the United States.
Market Cap
38.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#9,072 United States
PE Ratio
0.00
ChartMarket Cap Chart
Since January 11, 2017, Claritas Pharmaceuticals's market cap has decreased from 56.78M to 38.00, a decrease of -100.00%. That is a compound annual growth rate of -76.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 38.00 | - |
| Dec 24, 2024 | 38.00 | -98.66% |
| Dec 28, 2023 | 2.83K | -99.25% |
| Dec 30, 2022 | 377.87K | -92.96% |
| Dec 31, 2021 | 5.37M | -72.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genocea Biosciences | 59.00 |
| Better Therapeutics | 55.00 |
| Panacos Pharmaceuticals | 54.00 |
| Iterum Therapeutics | 53.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Intellipharmaceutics International | 33.00 |